Back to Results

Roche Holding Ltd ADR (RHHBY)

Roche Holding Ltd ADR is a depositary receipt tied to Roche Holding AG, a Swiss healthcare company with listed exposure to its underlying common shares. Through its pharmaceutical and diagnostics businesses, Roche serves customers across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. Its pharmaceutical portfolio covers treatment areas including anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory disorders, and transplantation. The diagnostics segment provides in vitro tests used in the assessment of diseases such as cancer, diabetes, Covid-19, hepatitis, and human papillomavirus, along with diagnostic instruments and digital health solutions. Roche was founded in 1896 and is headquartered in Basel, Switzerland.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap Free Float / Shares Outstanding Payout Ratio
OTC-RHHB.Y
$49.07
-11.8% Downside
Fair
$60.59
8.9% Upside
Fair
Great
1.8%
October 22, 2026
355 B
82.1%
63.2%
Valuation • Fair Value

Roche Holding Ltd ADR (OTC-RHHB.Y) Fair Value by Valuation Model

Review the available estimates for Roche Holding Ltd ADR (OTC-RHHB.Y), including EPV Fair Value.

Primary Valuation Read

Fair Value

$49.07

Estimated downside of 11.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

EPV Fair Value

$49.07

Earnings power value estimate.

Analyst Price Target

$60.59

Analysts imply upside of 8.9%.

How to read these valuation models

Use the 4 available valuation references for Roche Holding Ltd ADR (OTC-RHHB.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Roche Holding Ltd ADR (OTC-RHHB.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

77.922 B

Current operating scale indicator.

Revenue Forecast

76 B

Forward revenue estimate.

EBITDA

29.66 B

Current operating profitability reference.

EBITDA Forecast

30.972 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Roche Holding Ltd ADR (OTC-RHHB.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Roche Holding Ltd ADR (OTC-RHHB.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Roche Holding Ltd ADR (OTC-RHHB.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Roche Holding Ltd ADR (OTC-RHHB.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 22, 2026

Days to Earnings

30

Dividend Yield

1.8%

Current income yield reference.

Payout Ratio

63.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Roche Holding Ltd ADR (OTC-RHHB.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Roche Holding Ltd ADR (OTC-RHHB.Y) Stock Forecast & Technical Outlook

Review Roche Holding Ltd ADR (OTC-RHHB.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Roche Holding Ltd ADR (OTC-RHHB.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Roche Holding Ltd ADR (OTC-RHHB.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Roche Holding Ltd ADR (OTC-RHHB.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Roche Holding Ltd ADR (OTC-RHHB.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Roche Holding Ltd ADR (OTC-RHHB.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Roche Holding Ltd ADR (OTC-RHHB.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Roche Holding Ltd ADR (OTC-RHHB.Y) has a Hold consensus, with 2 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 4
Sell 0
FAQ • Fast Investor Answers

Roche Holding Ltd ADR (OTC-RHHB.Y) Stock FAQ

Data-supported answers about Roche Holding Ltd ADR (OTC-RHHB.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$49.07
Estimated downside 11.8%
Valuation Rating
Overvalued
Estimated downside of 11.8%
Analyst Target
$60.59
Implied upside 8.9%
Financial Health
Great
Current financial-health read

The current fair value estimate for Roche Holding Ltd ADR (OTC-RHHB.Y) is $49.07. This implies an estimated downside of 11.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 11.8% versus the current market price.

The available analyst price target for Roche Holding Ltd ADR (OTC-RHHB.Y) is $60.59. The analyst target implies estimated upside of 8.9%.

The current financial health read for Roche Holding Ltd ADR (OTC-RHHB.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Roche Holding Ltd ADR (OTC-RHHB.Y) is October 22, 2026.

Based on the current data, dividend yield is 1.8%.

The current market capitalization listed for Roche Holding Ltd ADR is 355 B.

The ticker symbol for Roche Holding Ltd ADR is OTC-RHHB.Y, and the stock is listed on OTC Markets.

Roche Holding Ltd ADR (OTC-RHHB.Y) is listed on OTC Markets.

The free float listed for Roche Holding Ltd ADR is 82.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,043 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 648.7 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 372.3 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 269.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 175.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 159.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 127.2 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 102 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.536 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 46.053 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.268 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.639 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 30.107 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.733 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.616 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Overvalued Market Cap 12.702 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.456 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.639 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.564 B